ERBB2 and breast carcinoma: The TNBC subtype exhibited the highest probability of breast-cancer-specific CODs by a significant margin at all intervals, especially in later months, with a cumulative probability of 20.15 ± 0.28%, followed by HER2+/HR− (12.81 ± 0.36%) at the 60th month.